1.Urethral sphincter preservation procedure in 165 cases of prostatectomy
Qiang BAI ; Zhensheng WANG ; Qing LI
Chinese Journal of Urology 2001;0(08):-
Objective To assess the urinary continence at a follow-up of 1 year after radical retro-pubic prostatectomy. Methods By using subjective (questionnaire) and objective (pad-test) methods, 165 consecutive prostate cancer patients were followed up at least 1 year. With the purpose to improve post-operative continence, surgical techniques such as preservation of external striated sphincter, preservation of bladder neck and pre-prostate sphincter (PPS), and nerve-sparing technique have been carried out.Analyses were also made in comparison by age. Results A post-operative incontinence rate of 0.7% was found in the sphincter preserving group and 5.3% in the sphincter repairing group. Patients aged 50~60 revealed a continence rate of 60% when the urethral catheter was removed, whereas 82% in the 60~70 group.After 3 months of follow-up, the continence rate of both age groups tended to be similar. Conclusions Surgical improvement and patients' age are important factors in post-operative continence after radical retro-pubic prostatectomy. The preservation of external urethral sphincter helps improve continence rate. Younger patients tend to regain to continence in a shorter period while the elders longer.
2.Application of the microprobe dredging operation in the treatment of the meibomian gland dysfunction (MGD)
Qing-Qiang, WANG ; Xin-Guo, JIA ; Wen-Bo, ZHANG ; Qing, FU ; Qiang, MA
International Eye Science 2014;(7):1269-1271
AlM: To evaluate the function of the microprobe dredging technology in the treatment of meibomian gland dysfunction ( MGD ) and to provide fast, efficient, economical and practical method of treatment for meibomian gland dysfunction ( MGD) .
METHODS:The 100μm diameter stainless steel wire was made as the microprobe with the total length of 3cm, which the needle was about 5mm and hand shank was about 2. 5cm. Selected 140 cases with dry eyes of meibomian gland dysfunction ( MGD ) , patients were divided into two groups and made them have comparability. Observation group ( n = 70 ) used microprobe to dredge meibomian gland pipe accompanied with drugs, hot compress and meibomian gland massage treatment. The control group (n=70) was given conventional drugs, hot compress and meibomian massage treatment. To compare the tear break-up time ( BUT) , efficient rate and the cure rate of the two groups after treatment of 1d, 1wk, 2wk, 1 mo, 2mo and 3mo.
RESULTS: BUT were significantly prolonged in observation group and control group after treatment, and the observation group improved more obviously; the efficient rate and cure rate of the observation group were significantly higher than that of the control group after 1d, 1wk, 2wk, 1mo, 2mo and 3mo treatment.
CONCLUSlON: Using microprobe to unclog the meibomian gland tube can provide the fast and efficient, economical and practical treatment for meibomian gland dysfunction ( MGD ) , which can be promoted in the clinical practice.
3.Prevention of prosthesis-patient mismatch during aortic valve replacement
Zhong WU ; Qing ZHOU ; Qiang WANG ; Jun PAN ; Dongjin WANG
Chinese Journal of Thoracic and Cardiovascular Surgery 2012;28(8):453-455
Objective The prosthesis used for aortic valve replacement (AVR) can be too small in relation to body size,thus causing valve prosthesis-patient mismatch (PPM).The aim of this article was to summarize the preventive strategy of PPM during AVR.Methods A total of 357 patients [203 males,154 females; mean age (54.9 ± 18.7 ) years ] underwent AVR between February.2010 and December 2011.The weight and body surface area (BSA) of the group is( 60.1 ± 11.4 )kg and (1.67 ± 0.21 )m2 respectively.The aortic valve prosthesis effective orifice area (EOA) was divided by body surface area (BSA) to obtain the EOA index (EOAI).PPM was then defined as none or mild if EOAI was > 0.85 cm2/m2,as moderate for (0.65 - 0.85 ) cm2/m2 and as severe for < 0.65 cm2/m2.To avoid PPM,a simple three-step algorithm was applied:Step 1,Calculate the patient's BSA from weight and height;Step 2,Calculate the minimal valve EOA required based on the BSA to ensure an EOAI >0.85 cm2/m2 ; Step 3,Select the type and size of prosthesis that has reference values for EOA greater or equal to the minimal EOA value obtained in step 2.For patients with a small aortic root,the following three methods was used:( 1 ) Replace aortic valve with simple interrupted suture technique ; (2) Apply new type and high-performance prosthetic valves such as St.Jude Medical Regent mechanical valve ; (3) Enlarge the narrowed aortic root when necessary.Results Of all 357 patients,272 patients received mechanical AVR and 85 bioprosthetic AVR.Among the 49 patients who received AVR with simple interrupted suture technique.St.Jude Medical Regent mechanical valve was implanted in 38 patients and the aortic root enlargement was performed in 11 patients.The total prevalence of PPM was 6.4% and there was no severe PPM.The prevalence of PPM with mechanical AVR and bioprosthetic AVR was 1.8% and 21.2% respectively.There were 4 deaths during early period of operation,and the operative mortality was 1.1%.Conclusion Prosthesis-patient mismatch can be effectively prevented at the time of AVR with appropriate measurement.
4.Management of cardiac surgery with cardiopulmonary bypass in pregnancy
Yulong XUAN ; Jun PAN ; Qing ZHOU ; Qiang WANG ; Dongjin WANG
Chinese Journal of Thoracic and Cardiovascular Surgery 2016;32(5):306-308
Cardiac surgery carried out on cardiopulmonary bypass(CPB) in a pregnant woman is associated with poor neonatal outcomes although maternal outcomes are similar to cardiac surgery in non-pregnant women.Most adverse maternal and fetal outcomes from cardiac surgery during pregnancy are attributed to effects of CPB.The CPB is associated with utero-placental hypoperfusion due to a number of factors,which may translate into low fetal cardiac output,hypoxia and even death.Better maternal and fetal outcomes may be achieved by early pre-operative optimization of maternal cardiovascular status,use of perioperative fetal monitoring,optimization of CPB,delivery of a viable fetus before the operation and scheduling cardiac surgery on an elective basis during the second trimester.
5.Yield and quality of Coptis chinensis from different varieties
Qiang ZHU ; Youwei WANG ; Haitao QI ; Qing WANG
Chinese Traditional and Herbal Drugs 1994;0(12):-
0.05), but the yields of four-year-old and five-year-old Dahuaye and Wuguangye samples were significantly higher than that of Xiaohuaye sample (P0.05). Conclusion The varieties of Dahuaye and Wuguangye are excellent in higher yield and better quality, and both of them can be used as origin seeds in the GAP plantation of C. chinensis.
6.Effects of amniotic membrane on proliferation and differentiation of human retinal pigment epithelial cell
Yao, WANG ; Hua-qing, GONG ; Ling-ling, YANG ; Qian, WANG ; Qing-jun, ZHOU ; Yi-qiang, WANG
Chinese Journal of Experimental Ophthalmology 2012;30(9):786-790
Background Human retinal pigment epithelial (RPE) cell transplantation treating retinal degenerative diseases is a researching topic,and the source of human RPE cells is a key problem.Many biological carriers can be used for the preparation of RPE cell layer.However,some advantages,such as cytotoxicity,lack of stability and immunologic reaction etc.are still existed.To study an ideal biological carrier is very important.Objective This experimental was to determine the effects of amniotic membrane on the proliferation and differentiation of human RPE cells and the possibility as a scaffold for RPE cell transplantation.Methods ARPE19 cell line cells were cultured and passaged in DMEM/F12 medium with 10% fetal bovine serum,and 8-12generation of cells were used.The cells were divided into two groups.One group of cells were incubated on the denuded amniotic membrane,and the other group of cells were cultured in the medium (control group).MTT was performed to detect the A492 value of RPE cells for the evaluation of cell proliferation ability 24,48,72,96 hours after culture.Cell morphology was compared by histopathological examination 3 weeks after culture.The mRNA expression of pigment epithelium-derived factor (PEDF),N-cadherin,β-catenin and cell connection related proteins in the cells of both groups were assayed using reverse transcription polymerase chain reaction (RT-PCR).Ultrastructure of the cells was observed under the transmission and scan electronic microscope 3 weeks after culture.Results The number of ARPE-19 cells cultured on denuded amniotic membrane was decreased significantly in comparison with the normal culture plate(F=41.760,P =0.000).Histopatholy also showed that the cell density on amniotic membrane was lower than of normal cells on plate surface.Moreover,the expression level of claudin 1 mRNA,N-cadherin mRNA and PEDF mRNA were significantly up-regulated in denuded amniotic membrane group in comparison with control group (t=15.828,P=0.000 ;t=6.839,P=0.002 ;t=14.667,P=0.000),but the expression of Connexin 43 mRNA was down-regulated in denuded amniotic membrane group compared with control group(t=3.358,P=0.024).Ultrastructural examination revealed that ARPE-19 cells cultured on amniotic membrane exhibited a polygonal epithelial phenotype with cilium on the apical side,however,the cells cultured on normal culture plate displayed fusiform shape and uneven thickness.Conclusions Amniotic membrane plays a promoting effect on the differentiation of ARPE-19 cells and a inhibitory effect on the proliferation of ARPE-19 cells,suggesting that amniotic membrane might be an useful scaffold for the preparation of functionally mature RPE cells for clinical transplantation.
7.Report of case with laryngeal nerve palsy and tracheal cartilage necrosis after thyroid microwave ablation.
Qing-quan ZHANG ; Shao-hong JIANG ; Qiang WANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2012;47(9):773-774
Cartilage
;
pathology
;
Catheter Ablation
;
adverse effects
;
methods
;
Female
;
Humans
;
Laryngeal Nerves
;
Microwaves
;
Middle Aged
;
Necrosis
;
Thyroid Gland
;
surgery
;
Trachea
;
pathology
;
Vocal Cord Paralysis
;
etiology
8.Type of adenoidal hypertrophy by nasal endoscopic and clinical significance.
Qing-quan ZHANG ; Qiang WANG ; Xiu-mei CHEN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2010;45(10):859-860
Adenoids
;
diagnostic imaging
;
pathology
;
surgery
;
Adolescent
;
Child
;
Child, Preschool
;
Endoscopy
;
Female
;
Humans
;
Hypertrophy
;
diagnostic imaging
;
pathology
;
surgery
;
Male
;
Nasopharyngeal Diseases
;
diagnostic imaging
;
pathology
;
surgery
;
Nose
;
surgery
;
Radiography
9.A case report of pterygopalatine fossa communication arachnoid cyst.
Qiang WANG ; Qing-quan ZHANG ; Shao-hong JIANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2013;48(3):250-251
Endoscopy
;
methods
;
Female
;
Humans
;
Meningocele
;
surgery
;
Middle Aged
;
Pterygopalatine Fossa
;
surgery
10.Mechanism and clinical progress of molecular targeted cancer therapy.
Hong-xiang HU ; Xue-qing WANG ; Hua ZHANG ; Qiang ZHANG
Acta Pharmaceutica Sinica 2015;50(10):1232-1239
Molecular target-based cancer therapy is playing a more and more important role in cancer therapy because of its high specificity, good tolerance and so on. There are different kinds of molecular targeted drugs such as monoclonal antibodies and small molecular kinase inhibitors, and more than 50 drugs have been approved since 1997. When the first monoclonal antibody, rituximab, was on the market. The development of molecular target-based cancer therapeutics has become the main approach. Based on this, we summarized the drugs approved by FDA and introduced their mechanism of actions and clinical applications. In order to incorporate most molecular targeted drugs and describe clearly various characteristics, we divided them into four categories: drugs related to EGFR, drugs related to antiangiogenesis, drugs related to specific antigen and other targeted drugs. The purpose of this review is to provide a current status of this field and discover the main problems in the molecular targeted therapy.
Angiogenesis Inhibitors
;
Antibodies, Monoclonal
;
Drug Delivery Systems
;
Humans
;
Molecular Targeted Therapy
;
Neoplasms
;
drug therapy
;
Protein Kinase Inhibitors
;
Receptor, Epidermal Growth Factor
;
antagonists & inhibitors